Brii Biosciences Financials
| BRIBF Stock | USD 0.30 0.17 130.77% |
Brii |
Understanding current and past Brii Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Brii Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Brii Biosciences' assets may result in an increase in income on the income statement.
Brii Biosciences Stock Summary
Brii Biosciences competes with Avalo Therapeutics, Alzamend Neuro, Virax Biolabs, Benitec Biopharma, and Cardio Diagnostics. Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company was incorporated in 2017 and is based in Beijing, China. Brii Bioscience is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Building 7, Beijing, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.briibio.com |
| Currency | USD - US Dollar |
Brii Biosciences Key Financial Ratios
There are many critical financial ratios that Brii Biosciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Brii Biosciences reports annually and quarterly.Brii Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Brii Biosciences's current stock value. Our valuation model uses many indicators to compare Brii Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brii Biosciences competition to find correlations between indicators driving Brii Biosciences's intrinsic value. More Info.Brii Biosciences Limited is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brii Biosciences' earnings, one of the primary drivers of an investment's value.Brii Biosciences Systematic Risk
Brii Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Brii Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Brii Biosciences correlated with the market. If Beta is less than 0 Brii Biosciences generally moves in the opposite direction as compared to the market. If Brii Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Brii Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Brii Biosciences is generally in the same direction as the market. If Beta > 1 Brii Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
Brii Biosciences March 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Brii Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Brii Biosciences Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Brii Biosciences Limited based on widely used predictive technical indicators. In general, we focus on analyzing Brii Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Brii Biosciences's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1267 | |||
| Maximum Drawdown | 130.77 |
Complementary Tools for Brii Pink Sheet analysis
When running Brii Biosciences' price analysis, check to measure Brii Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brii Biosciences is operating at the current time. Most of Brii Biosciences' value examination focuses on studying past and present price action to predict the probability of Brii Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brii Biosciences' price. Additionally, you may evaluate how the addition of Brii Biosciences to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |